The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
about
Liver cancer stem cell markers: Progression and therapeutic implicationsResearch progress and prospects of markers for liver cancer stem cellsOverexpression of CD90 (Thy-1) in pancreatic adenocarcinoma present in the tumor microenvironmentHeterogeneity of The CD90(+) Population in Different Stages of Hepatocarcinogenesis.The role of multipotent cancer associated fibroblasts in hepatocarcinogenesisProfiles of cancer stem cell subpopulations in cholangiocarcinomas.CD90+ liver cancer cells modulate endothelial cell phenotype through the release of exosomes containing H19 lncRNA.Transcriptomic characterization of fibrolamellar hepatocellular carcinoma.The Notch pathway promotes the cancer stem cell characteristics of CD90+ cells in hepatocellular carcinomaEffective elimination of liver cancer stem-like cells by CD90 antibody targeted thermosensitive magnetoliposomes.Overexpression of Thy1 and ITGA6 is associated with invasion, metastasis and poor prognosis in human gallbladder carcinoma.Extracellular vesicles-mediated noncoding RNAs transfer in cancer.Role of C-X-C chemokine ligand 12/C-X-C chemokine receptor 4 in the progression of hepatocellular carcinoma.Autocrine and Paracrine Mechanisms Promoting Chemoresistance in Cholangiocarcinoma.Identification, expansion and characterization of cancer cells with stem cell properties from head and neck squamous cell carcinomas.Combination of 5-fluorouracil and 2-morphilino-8-phenyl-4H-chromen-4-one may inhibit liver cancer stem cell activity.CD90 a potential cancer stem cell marker and a therapeutic target.Multiple roles of CD90 in cancer.Expert consensus document: Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA).Myrtucommulone-A treatment decreases pluripotency- and multipotency-associated marker expression in bladder cancer cell line HTB-9.Targeting cancer stem cells by using chimeric antigen receptor-modified T cells: a potential and curable approach for cancer treatment.Biliary tract cancer stem cells - translational options and challenges.A reduction in CD90 (THY-1) expression results in increased differentiation of mesenchymal stromal cells.CD90 promotes cell migration, viability and sphere‑forming ability of hepatocellular carcinoma cells.New insights into cholangiocarcinoma: multiple stems and related cell lineages of origin.Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs.Defining Skin Fibroblastic Cell Types Beyond CD90Activation of hepatic stem cells compartment during hepatocarcinogenesis in a HBsAg HBV-transgenic mouse model
P2860
Q26751026-B6C843DB-EF8C-4330-8BF6-9AD5D1A74198Q27022262-AB366B2F-BDC2-419D-A9A0-FD8F9532881EQ34764691-E94DBEFA-E236-4043-8CDD-3E38EE3E888CQ34845447-934D3301-5E7F-4D92-A694-1094CEB3979AQ35318778-BCD08965-7C70-4DD0-9B5F-FF7141B5FF9DQ35669078-0250EFF7-0677-4211-8F73-4244F3859B58Q35954464-F5668AFA-1321-43C1-B67F-BCACC2BEAD8BQ36268536-09BEDE64-86F0-4383-B91D-5342663D0BF6Q36962663-0E201D79-94ED-4D9B-BE03-36E0842A31BBQ37392604-CFF37BA7-0B60-476B-8D94-068765E08474Q37582429-AE87F5E1-D8A6-4456-BF56-2B422E7DC0EFQ37663393-86152FE7-54BE-462D-8799-C757A37536E6Q38645374-BC80BB16-3B65-4422-99AA-50ADB35DF47CQ38720813-985A0575-F1D2-4561-AC02-955AE7AB4CB8Q38746734-82A40E55-D1E5-4A13-A470-9618A2A966C8Q38793468-DE628694-9C4A-4BB4-B148-AF5C6D5DD42CQ38803617-EEA96D4B-9AB7-4969-8523-5C1CFB4D8C9DQ38805813-F646032B-7E07-4AF0-8893-DB8B4B98E022Q38812588-2AC41A90-1CB6-4297-A9AA-9A41576A7C3BQ38866185-FA8D81B2-B487-41ED-83ED-3BD09A4AD9ABQ39177087-395F5069-337D-48F0-9DA6-D6C007428502Q39279276-A926676E-EAAA-4EE9-8A92-890512F9A70CQ42049959-6F810AF1-BC6A-4B95-BD3B-90A5DAF706DBQ47292629-83B0CCE4-010D-4B7C-8AE8-EEE303FB8E02Q50050635-E51110BA-9F44-4484-898B-E232BD97697BQ53221564-BD227055-504E-4F2D-9180-90B49F458AB8Q58580276-E0D41712-5455-41DF-9F24-784CAAF407F1Q58769412-DDE34F70-587F-475F-8126-EAAC1E3054FE
P2860
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
@ast
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
@en
type
label
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
@ast
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
@en
prefLabel
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
@ast
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
@en
P2093
P2860
P50
P1433
P1476
The expression of CD90/Thy-1 in hepatocellular carcinoma: an in vivo and in vitro study
@en
P2093
Giuliano Torre
Lory Saveria Crocè
Paola Francalanci
P2860
P304
P356
10.1371/JOURNAL.PONE.0076830
P407
P577
2013-10-08T00:00:00Z